Diabetes Treatments Targeting Postprandial Endothelial Dysfunction Reduce CVD Risk with GLP-1 and Physical Activity
-
- STATUS
- Not Recruiting
Updated on 19 February 2024
Summary
This study is attempting to apply established diabetes treatments in new ways.
Description
We are applying established treatments in novel ways, challenging the existing diabetes treatment paradigm with the concept of the importance of postprandial endothelial function as a specific target for the prevention of ACVD in DM2. Because of the high
Details
| Condition | Diabetes - Type II |
|---|---|
| Age | 18years - 65years |
| Clinical Study Identifier | TX2100 |
| Last Modified on | 19 February 2024 |
How understandable was the trial content above?
Hard to understand
Easy to understand
Similar trials to consider
Loading...
Not finding what you're looking for?
Sign up as a volunteer to stay informed
Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.
Sign up as volunteerStudy Definition
WikipediaAdd a private note
- Select a piece of text.
- Add notes visible only to you.
- Send it to people through a passcode protected link.